Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism Glutaminyl-peptide cyclotransferase inhibitors, QPCTL inhibitors(glutaminyl-peptide cyclotransferase like inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Inflammation | Preclinical | Germany | 01 Feb 2025 | |
| Chronic Kidney Diseases | Preclinical | Germany | 14 Jan 2025 | |
| Diabetic Nephropathies | Preclinical | Germany | 14 Jan 2025 | |
| Fibrosis | Preclinical | Germany | 14 Jan 2025 |





